These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 32424515)
1. Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study. Rosiello G; Pecoraro A; Palumbo C; Knipper S; Luzzago S; Deuker M; Tian Z; Gandaglia G; Fossati N; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI World J Urol; 2021 Mar; 39(3):813-822. PubMed ID: 32424515 [TBL] [Abstract][Full Text] [Related]
2. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion. Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842 [TBL] [Abstract][Full Text] [Related]
3. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341 [TBL] [Abstract][Full Text] [Related]
4. Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis? Mazzone E; Knipper S; Mistretta FA; Tian Z; Preisser F; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI Cancer Epidemiol; 2019 Feb; 58():83-88. PubMed ID: 30528834 [TBL] [Abstract][Full Text] [Related]
5. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract. Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285 [TBL] [Abstract][Full Text] [Related]
6. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder. Luzzago S; Palumbo C; Rosiello G; Pecoraro A; Deuker M; Tian Z; Shariat SF; Saad F; de Cobelli O; Karakiewicz PI J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831 [TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting. Kwon T; Jeong IG; Lee J; Lee C; You D; Hong B; Hong JH; Ahn H; Kim CS J Cancer Res Clin Oncol; 2015 Jan; 141(1):169-76. PubMed ID: 25119986 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
9. Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder. Deuker M; Franziska Stolzenbach L; Rosiello G; Luzzago S; Martin T; Tian Z; Tilki D; Shariat SF; Saad F; Kassouf W; Black PC; Chun FKH; Karakiewicz PI Eur J Surg Oncol; 2021 Feb; 47(2):463-469. PubMed ID: 32457017 [TBL] [Abstract][Full Text] [Related]
10. Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis. Barletta F; Tappero S; Panunzio A; Incesu RB; Cano Garcia C; Piccinelli ML; Tian Z; Gandaglia G; Moschini M; Terrone C; Antonelli A; Tilki D; Chun FKH; De Cobelli O; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI Urol Oncol; 2023 Mar; 41(3):147.e1-147.e6. PubMed ID: 36428165 [TBL] [Abstract][Full Text] [Related]
11. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes. Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182 [TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder. Stensland KD; Zaid H; Broadwin M; Sorcini A; Canes D; Galsky M; Moinzadeh A Eur Urol Oncol; 2020 Aug; 3(4):509-514. PubMed ID: 31411987 [TBL] [Abstract][Full Text] [Related]
14. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study. Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry. Staník M; Poprach A; Zapletalová M; Krejčí D; Macík D; Čapák I; Jarkovský J; Lakomý R; Doležel J Clin Genitourin Cancer; 2019 Aug; 17(4):e759-e767. PubMed ID: 31101578 [TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients. Sorce G; Flammia RS; Hoeh B; Chierigo F; Horlemann B; Würnschimmel C; Tian Z; Graefen M; Terrone C; Gallucci M; Chun FKH; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI World J Urol; 2022 Jun; 40(6):1481-1488. PubMed ID: 35084543 [TBL] [Abstract][Full Text] [Related]
17. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder. Mazzone E; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Gallina A; Soulieres D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer. Pak S; You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Kim CS; Ahn H Sci Rep; 2019 Jun; 9(1):8305. PubMed ID: 31165753 [TBL] [Abstract][Full Text] [Related]
19. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Berg S; D'Andrea D; Vetterlein MW; Cole AP; Fletcher SA; Krimphove MJ; Marchese M; Lipsitz SR; Sonpavde G; Noldus J; Shariat SF; Kibel AS; Trinh QD; Mossanen M Cancer; 2019 May; 125(9):1449-1458. PubMed ID: 30620387 [TBL] [Abstract][Full Text] [Related]
20. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A; BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]